                         SEQUENCE LISTING

<110>  EIGER BIOPHARMACEUTICALS, INC.
 
<120>  TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA WITH EXENDIN-4 
       DERIVATIVES

<130>  1037358

<140>  PCT/US2017/020596
<141>  2017-03-03

<150>  US 62/303,983
<151>  2016-03-04

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(3-39)

<400>  1

Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala 
1               5                   10                  15      


Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly 
            20                  25                  30          


Ala Pro Pro Pro Ser 
        35          


<210>  2
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(4-39)

<400>  2

Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala Val 
1               5                   10                  15      


Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly Ala 
            20                  25                  30          


Pro Pro Pro Ser 
        35      


<210>  3
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(5-39)

<400>  3

Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala Val Arg 
1               5                   10                  15      


Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly Ala Pro 
            20                  25                  30          


Pro Pro Ser 
        35  


<210>  4
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(6-39)

<400>  4

Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala Val Arg Leu 
1               5                   10                  15      


Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly Ala Pro Pro 
            20                  25                  30          


Pro Ser 
        


<210>  5
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(7-39)

<400>  5

Thr Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala Val Arg Leu Phe 
1               5                   10                  15      


Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro 
            20                  25                  30          


Ser 
    


<210>  6
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic exendin-4 derivative, exendin(8-39)

<400>  6

Ser Asp Leu Ser Lys Gln Met Glu Glu Glu Ala Val Arg Leu Phe Ile 
1               5                   10                  15      


Glu Trp Leu Lys Asn Gly Gly Pro Ser Ser Gly Ala Pro Pro Pro Ser 
            20                  25                  30          


